Androgen-deprivation therapy and risk of dementia in patients with prostate cancer: Clinical outcomes from real-world data

被引:0
|
作者
Elantably, Dina
Wang, Jiasheng
Al Armashi, Abdul Rahman
Al Zubaidi, Anas
Alkrekshi, Akram
机构
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Seidman Canc Ctr, Dept Hematol & Oncol, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Case Comprehens Canc Ctr, Seidman Canc Ctr, Cleveland, OH 44106 USA
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[5] Case Western Reserve Univ, MetroHlth Med Ctr, Dept Hematol & Oncol, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5086
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Depression and androgen-deprivation therapy for advanced prostate cancer
    Savard, J.
    Simard, S.
    Hervouet, S.
    Ivers, H.
    Rioux, D.
    PSYCHO-ONCOLOGY, 2007, 16 (09) : S151 - S152
  • [22] REAL-WORLD EVALUATION OF PHYSICIAN ATTITUDES TOWARDS THE PRESCRIPTION OF ANDROGEN DEPRIVATION THERAPY FOR PATIENTS WITH PROSTATE CANCER
    Wittny-Jensen, K. U.
    Hallworth, P.
    Alvarez, M. L.
    Rider, A.
    VALUE IN HEALTH, 2017, 20 (09) : A462 - A463
  • [23] Depression and androgen-deprivation therapy for advanced prostate cancer
    Savard, Josee
    Simard, Sebastian
    Hervouet, Severine
    Ivers, Hans
    Rioux, Dominique
    ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S89 - S89
  • [24] Androgen deprivation therapy, neoadjuvant androgen deprivation therapy, and adjuvant androgen deprivation therapy in patients with locally advanced prostate cancer: a multi-center real-world retrospective study
    Yi, Zhenglin
    Li, Huihuang
    Li, Mingyong
    Hu, Jiao
    Cai, Zhiyong
    Liu, Zhi
    Zhang, Chunyu
    Cheng, Chunliang
    He, Yunbo
    Chen, Jinbo
    Zu, Xiongbing
    Wang, Ruizhe
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [25] Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer
    Aragon-Ching, Jeanny B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06): : 579 - 580
  • [26] Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Saad, Fred
    Egerdie, Blair
    Sieber, Paul R.
    Tammela, Teuvo L. J.
    Ke, Chunlei
    Leder, Benjamin Z.
    Goessl, Carsten
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3271 - 3276
  • [27] Reversible Parkinson's Dementia Associated with Withdrawal of Androgen-Deprivation Therapy for Prostate Cancer
    Abbate, Carlo
    Caputo, Ludovica
    Damanti, Sarah
    Zappa, Carlo
    Nicolini, Paola
    Rossi, Paolo D.
    Arosio, Beatrice
    Mari, Daniela
    De Riz, Milena A.
    Dormia, Guido
    Trimarchi, Pietro D.
    Morello, Elisabetta
    Monfardini, Silvio
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 (10) : E115 - E117
  • [28] A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients
    C Jin
    Y Fan
    Y Meng
    C Shen
    Y Wang
    S Hu
    C Cui
    T Xu
    W Yu
    J Jin
    Prostate Cancer and Prostatic Diseases, 2016, 19 : 333 - 339
  • [29] Does androgen-deprivation therapy for prostate cancer increase the risk for thromboembolic disease?
    Pinthus, Jehonathan H.
    Duivenvoorden, Wilhelmina C.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (1-2): : 39 - 40
  • [30] Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer
    Jiunn-Bey Pao
    Ying-Pi Yang
    Chun-Nung Huang
    Shu-Pin Huang
    Tzyh-Chyuan Hour
    Ta-Yuan Chang
    Yu-Hsuan Lan
    Te-Ling Lu
    Hong-Zin Lee
    Shin-Hun Juang
    Chao-Yuan Huang
    Bo-Ying Bao
    World Journal of Urology, 2013, 31 : 281 - 287